Case CMEPrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Management of Mild-to-Moderate Osteoarthritic Pain CME/CE
Author: Michele Hooper, MD, MS
Disclosures

Release Date: September 30, 2005; Valid for credit through September 30, 2006

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.

Contents of This CME/CE Activity
  1. Management of Mild-to-Moderate Osteoarthritic Pain
    Introduction
    Case Scenario
    Answer Explanations
    Clinical Course
    Discussion
    References

Editor's Note:
Emerging information is creating debate about whether the benefits of COX-2 inhibitors ("coxibs") outweigh their cardiovascular risks. In addition, possible adverse effects of standard NSAIDs on the cardiovascular system are under scrutiny. Physicians as well as patients are uncertain about the optimal use of these agents. Medscape's NSAIDs and Cardiovascular Effects Alert Center provides links to articles and/or policy statements that update the evidence in this important therapeutic area. This Center is not intended to be a definitive source on the subject.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2005 Medscape.

 
McNeil
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME/CE Information
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape designates this educational activity for a maximum of 1.0 Category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that reflect the time he/she actually spent in the activity.

Contact This Provider

 
NPA, Inc.
This Activity is sponsored by Nurse Practitioner Alternatives, Inc. as a provider of continuing education in nursing through the Maryland Nurses Association which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center's Commission on Accreditation.

Approved for 1.2 contact hour(s) of continuing education for RNs, LPNs, LVNs and NPs; 0.6 credits are in the area of pharmacology. This program is coprovided with Nurse Practitioner Alternatives, Inc., (NPA) and Medscape. NPA is accredited as a provider of continuing nursing education by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Provider Number: PN04-2-910-809

Contact This Provider

 
MEC
ACPE logo1.25 contact hour(s) (0.125 CEUs) of credit for pharmacists. Approval of this course for pharmacists is under a cosponsorship agreement between Medical Education Collaborative, Inc. (MEC) and Medscape. MEC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE # 815-999-05-105-H01. The program is designed for all pharmacists.

For questions regarding the pharmacy accreditation of this activity, please contact Medical Education Collaborative at (303)420-3252.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.